Effects of the tumor promoter 2-acetylaminofluorene and of 4-acetylaminofluorene on rat liver growth.
2-Acetylaminofluorene (2-AAF) is a moderately cytotoxic drug which is nevertheless capable of promoting diethylnitrosamine-initiated rat liver carcinogenesis in the absence of detectable hepatotoxicity. 2-AAF does not stimulate net growth of the normal liver, but alters hepatocellular ploidy distributions (fewer binucleated and more diploid cells) in a manner indicative of altered growth control. The non-cytotoxic analogue 4-AAF induces a similar ploidy change, and also stimulates liver growth. The possibility should therefore be considered that both agents may specifically elicit a mononucleating growth response in normal liver, which in the case of 2-AAF is antagonized by a general (cytotoxic) growth inhibition. In the promotion of liver carcinogenesis, 2-AAF may act as a growth stimulant upon cytotoxicity-resistant initiated cells; cytotoxicity per se playing no causative role.